Cancer embryonic antigen (CEA) levels in patients with appendiceal adenocarcinoma predict response to neo‐adjuvant chemotherapy and overall survival
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.27178
Abstract: Serum tumor markers are widely used for diagnosis, prognosis, treatment response, and surveillance. Our study evaluated cancer embryonic antigen (CEA) in patients with appendiceal adenocarcinoma. read more here.
Keywords: antigen cea; appendiceal adenocarcinoma; cancer embryonic; response ... See more keywords